I

Ilex Medical Ltd
TASE:ILX

Watchlist Manager
Ilex Medical Ltd
TASE:ILX
Watchlist
Price: 6 755 ILS 1.58%
Market Cap: 754.9m ILS
Section:
 

Relative Value

The Relative Value of one ILX stock under the Base Case scenario is hidden ILS. Compared to the current market price of 6 755 ILS, Ilex Medical Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ILX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
61
vs Industry
71
Median 3Y
0.8
Median 5Y
0.9
Industry
2.3
More Details
16.6
P/E
P/E
Price to Earnings
16.6
vs History
9
vs Industry
35
Median 3Y
13.9
Median 5Y
10.8
Industry
22.5
More Details
9.2
P/OCF
P/OCF
Price to OCF
9.2
vs History
20
vs Industry
45
Median 3Y
8.9
Median 5Y
8.3
Industry
14.4
More Details
22.9
P/FCFE
P/FCFE
Price to FCFE
22.9
vs History
30
vs Industry
31
Median 3Y
22.9
Median 5Y
16
Industry
21.4
More Details
1.1
P/B
P/B
Price to Book Value
1.1
vs History
71
vs Industry
59
Median 3Y
1.2
Median 5Y
1.4
Industry
2.2
More Details
0.6
EV/S
EV/S
Enterprise Value to Sales
0.6
vs History
65
vs Industry
77
Median 3Y
0.6
Median 5Y
0.7
Industry
2.5
More Details
2.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.5
vs History
53
vs Industry
63
Median 3Y
2.4
Median 5Y
2.7
Industry
5.2
More Details
4.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.8
vs History
15
vs Industry
48
Median 3Y
4.4
Median 5Y
4.3
Industry
11.9
More Details
8.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
8.6
vs History
6
vs Industry
42
Median 3Y
7
Median 5Y
6.2
Industry
16.8
More Details
6.6
EV/OCF
EV/OCF
Enterprise Value to OCF
6.6
vs History
23
vs Industry
48
Median 3Y
6.5
Median 5Y
6
Industry
14.5
More Details
11.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
11.2
vs History
28
vs Industry
37
Median 3Y
11
Median 5Y
9.6
Industry
18.6
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
63
vs Industry
61
Median 3Y
1
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

ILX Competitors Multiples
Ilex Medical Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Ilex Medical Ltd
TASE:ILX
754.9m ILS 0.8 16.6 4.8 8.6
US
Mckesson Corp
NYSE:MCK
102.1B USD 0.3 25.3 17.8 20.1
US
Amerisourcebergen Corp
LSE:0HF3
65.8B USD 0.2 42.3 14.3 18.4
US
Cencora Inc
NYSE:COR
65.7B USD 0.2 42.3 14.3 18.4
US
Cardinal Health Inc
NYSE:CAH
49B USD 0.2 30.7 15.1 19.8
AU
Sigma Healthcare Ltd
ASX:SIG
33.8B AUD 5.6 63.8 48.2 48.2
CN
Huadong Medicine Co Ltd
SZSE:000963
69.2B CNY 1.6 18.7 14.5 14.5
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
66.2B CNY 0.2 11.7 15.5 15.5
US
Henry Schein Inc
NASDAQ:HSIC
9.1B USD 0.7 23.3 11.2 15.7
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Sinopharm Group Co Ltd
HKEX:1099
61.6B HKD 0.1 8.1 1.4 1.8

See Also

Summary
ILX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ILX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ILX stock valuation using valuation multiples.
Wall Street Estimates
ILX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ILX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 307,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.